Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1991.81x is 140% below its 2-year average of -831.35x, near the low end of its 2-year range (-1991.81x–-293.22x).
As of the fiscal period ended Thursday, March 31, 2022.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2022 (2022-03-31): -1991.81x.
INTEREST COVERAGE RATIO
-1991.81x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 432 covered companies
CURRENT VS SECTOR MEDIAN
-35853.23%
vs the sector median at left
Gain Therapeutics, Inc.
Market Cap
$74.00M
Interest Coverage Ratio
-1991.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70.95M
Interest Coverage Ratio
N/A
TTM Avg
933.58x
3Y Avg
933.58x
5Y Avg
933.58x
Market Cap
$77.29M
Interest Coverage Ratio
-4.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.80M
Interest Coverage Ratio
-23.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.26M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.76M
Interest Coverage Ratio
N/A
TTM Avg
273.61x
3Y Avg
273.61x
5Y Avg
273.61x
Market Cap
$68.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $74.00M | -1991.81x | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.53M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $70.95M | N/A | 933.58x | 933.58x | 933.58x |
| Outset Medical, Inc. (OM)vs › | $77.29M | -4.78x | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | -23.23x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $69.26M | -8.06x | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.76M | N/A | 273.61x | 273.61x | 273.61x |
| iBio, Inc. (IBIO)vs › | $68.81M | -663.04x | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $68.77M | N/A | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -17.01x | N/A | N/A | N/A |
Interest Coverage
-1991.8x
Debt/Equity
0.05
Current Ratio
4.36
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-03-31 | -1991.81x |
| 2020-06-30 | -351.00x |
| 2020-03-31 | -293.22x |
| 2019-12-31 | -689.37x |
